Ventricular assist devices offer a promising alternative to heart transplantation for advanced heart failure, with technological advances expanding the eligible patient population.
This review outlines criteria for patient selection for ventricular assist devices in advanced heart failure, highlighting that technological advancements are expanding the eligible patient population.
The number of patients with advanced heart failure that has become unresponsive to conventional medical therapy is increasing rapidly. One of the most promising new alternatives to heart transplantation is use of ventricular assist devices (VADs). To date, there are no guidelines for appropriate selection for use of these devices that are approved by national societies in the field. This review addresses all of the general criteria for clinicians to keep in mind regarding when to refer a patient for evaluation and the specific issues addressed in patient selection. The field of mechanical circulatory support has advanced significantly over the past 10 years, resulting in rapid expansion of patients with advanced heart failure who can benefit from implantable devices. With progress of technology, limitations associated with age, body size, and comorbidities gradually become less prohibitive. The continuing simplification of design along with continued reduction in size of the devices, plus eventual elimination of the external drive line will make the use of VADs a superior option to heart transplant and even to medical management in many patients. We anticipate that the patient selection process outlined in the present review will continue to shift toward less advanced cases of heart failure.
Miller et al. (Wed,) conducted a review in Advanced heart failure. Ventricular assist devices (VADs) was evaluated. Ventricular assist devices offer a promising alternative to heart transplantation for advanced heart failure, with technological advances expanding the eligible patient population.